BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37942479)

  • 1. Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis.
    Wang L; Guzman M; Muñoz-Santos D; Honrubia JM; Ripoll-Gomez J; Delgado R; Sola I; Enjuanes L; Zuñiga S
    Front Cell Infect Microbiol; 2023; 13():1268227. PubMed ID: 37942479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.
    Malicoat J; Manivasagam S; Zuñiga S; Sola I; McCabe D; Rong L; Perlman S; Enjuanes L; Manicassamy B
    J Virol; 2022 Feb; 96(3):e0183721. PubMed ID: 34851142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.
    Luo Y; Yu F; Zhou M; Liu Y; Xia B; Zhang X; Liu J; Zhang J; Du Y; Li R; Wu L; Zhang X; Pan T; Guo D; Peng T; Zhang H
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
    Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
    Nguyen HT; Falzarano D; Gerdts V; Liu Q
    J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
    Tanaka T; Saito A; Suzuki T; Miyamoto Y; Takayama K; Okamoto T; Moriishi K
    Antiviral Res; 2022 Mar; 199():105268. PubMed ID: 35271914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis.
    Feng X; Zhang X; Jiang S; Tang Y; Cheng C; Krishna PA; Wang X; Dai J; Zeng J; Xia T; Zhao D
    Comput Struct Biotechnol J; 2022; 20():5193-5202. PubMed ID: 36059866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery.
    Jin YY; Lin H; Cao L; Wu WC; Ji Y; Du L; Jiang Y; Xie Y; Tong K; Xing F; Zheng F; Shi M; Pan JA; Peng X; Guo D
    Virol Sin; 2021 Oct; 36(5):913-923. PubMed ID: 33999369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
    Gutiérrez-Álvarez J; Honrubia JM; Sanz-Bravo A; González-Miranda E; Fernández-Delgado R; Rejas MT; Zúñiga S; Sola I; Enjuanes L
    Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34686605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Takazawa S; Kotaki T; Nakamura S; Utsubo C; Kameoka M
    Virus Res; 2023 Sep; 334():199176. PubMed ID: 37473963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication.
    Wang X; Zhu Y; Wu Q; Jiang N; Xie Y; Deng Q
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis.
    Almazán F; Dediego ML; Galán C; Escors D; Alvarez E; Ortego J; Sola I; Zuñiga S; Alonso S; Moreno JL; Nogales A; Capiscol C; Enjuanes L
    J Virol; 2006 Nov; 80(21):10900-6. PubMed ID: 16928748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes.
    Ye C; Martinez-Sobrido L
    Microbiol Spectr; 2022 Dec; 10(6):e0273222. PubMed ID: 36342302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    Liu S; Chou CK; Wu WW; Luan B; Wang TT
    J Virol; 2022 Mar; 96(6):e0221621. PubMed ID: 35080424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication and single-cycle delivery of SARS-CoV-2 replicons.
    Ricardo-Lax I; Luna JM; Thao TTN; Le Pen J; Yu Y; Hoffmann HH; Schneider WM; Razooky BS; Fernandez-Martinez J; Schmidt F; Weisblum Y; Trüeb BS; Berenguer Veiga I; Schmied K; Ebert N; Michailidis E; Peace A; Sánchez-Rivera FJ; Lowe SW; Rout MP; Hatziioannou T; Bieniasz PD; Poirier JT; MacDonald MR; Thiel V; Rice CM
    Science; 2021 Nov; 374(6571):1099-1106. PubMed ID: 34648371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release.
    Tian L; Liu Q; Pei R; Chen Y; Xu C; Tang J; Sun H; Liu K; Yang Q; Yang L; Li L; Zhang Y; Zhou Y; Shan C; Hu X; Chen X; Wang Y
    Virol Sin; 2022 Oct; 37(5):695-703. PubMed ID: 35781091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2.
    Chiem K; Nogales A; Almazán F; Ye C; Martínez-Sobrido L
    Methods Mol Biol; 2024; 2733():133-153. PubMed ID: 38064031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.